Eicosis Human Health Inc.

This study tests an experimental oral drug called EC5026 in 18 adults with Parkinson's disease. The main goal is to see if the drug is safe and how it works in the body, but researchers will also check if it helps improve symptoms. Participants take the drug or a placebo daily fo…

This early-stage study tests a new oral drug, EC5026, in 36 adults with spinal cord injury who have nerve pain. The main goal is to check safety and tolerability over 14 days, while also seeing if it reduces pain compared to a placebo. Participants take one pill daily and undergo…